Home LiteratureArticle Details
PMID: 10783169 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Genes & development ·Vol. 14 ·No. 8 ·2000-04-15 ·Pages 981-93

Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ

Abstract

Oligonucleotide microarrays were employed to quantitate mRNA levels from a large number of genes regulated by the p53 transcription factor. Responses to DNA damage and to zinc-inducible p53 were compared for their transcription patterns in cell culture. A cluster analysis of these data demonstrates that genes induced by gamma radiation, UV radiation, and the zinc-induced p53 form distinct sets and subsets with a few genes in common to all these treatments. Cell type- or cell line-specific p53 responses were detected. When p53 proteins were induced with zinc, the kinetics of induction or repression of mRNAs from p53-responsive genes fell into eight distinct classes, five different kinetics of induction, and three different kinetics of repression. In addition, low levels of p53 in a cell induced or repressed only a subset of genes observed at higher p53 levels. The results of this study demonstrate that the nature of the p53 response in diverse mRNA species depends on the levels of p53 protein in a cell, the type of inducing agent or event, and the cell type employed. Of 6000 genes examined for p53 regulatory responses, 107 induced and 54 repressed genes fell into categories of apoptosis and growth arrest, cytoskeletal functions, growth factors and their inhibitors, extracellular matrix, and adhesion genes.

MeSH Terms
Chlorides/metabolism Cluster Analysis DNA, Complementary/metabolism Dose-Response Relationship, Drug Gene Expression Genes, p53/genetics Humans Oligonucleotide Array Sequence Analysis Reverse Transcriptase Polymerase Chain Reaction Time Factors Transfection Tumor Cells, Cultured Zinc Compounds/metabolism
Chemicals
Chlorides DNA, Complementary Zinc Compounds zinc chloride
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Zhao R
Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA.
Gish K
Murphy M
Yin Y
Notterman D
Hoffman W H
Tom E
Mack D H
Levine A J
References (60)
60 references, click to expand
  1. Identification of p53 as a sequence-specific DNA-binding protein.
    Science. 1991 Jun 21;252(5013):1708-11 PMID: 2047879
  2. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Science. 1994 Jul 15;265(5170):346-55 PMID: 8023157
  3. Mutational spectra and immunohistochemical analyses of p53 in human cancers.
    Chest. 1992 Mar;101(3 Suppl):19S-20S PMID: 1541189
  4. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Nature. 1992 Mar 19;356(6366):215-21 PMID: 1552940
  5. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.
    EMBO J. 1992 Apr;11(4):1383-90 PMID: 1314165
  6. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4495-9 PMID: 1584781
  7. Wild-type p53 activates transcription in vitro.
    Nature. 1992 Jul 2;358(6381):83-6 PMID: 1614538
  8. Wild-type p53 binds to the TATA-binding protein and represses transcription.
    Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12028-32 PMID: 1465435
  9. Definition of a consensus binding site for p53.
    Nat Genet. 1992 Apr;1(1):45-9 PMID: 1301998
  10. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.
    Nature. 1993 May 20;363(6426):281-3 PMID: 8387645
  11. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.
    Oncogene. 1993 Jun;8(6):1693-6 PMID: 8502489
  12. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  13. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  14. p21 is a universal inhibitor of cyclin kinases.
    Nature. 1993 Dec 16;366(6456):701-4 PMID: 8259214
  15. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
    Genes Dev. 1993 Dec;7(12B):2556-64 PMID: 8276238
  16. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Genes Dev. 1993 Dec;7(12B):2565-74 PMID: 8276239
  17. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Genes Dev. 1993 Dec;7(12B):2575-86 PMID: 8276240
  18. Sequence-specific transcriptional activation is essential for growth suppression by p53.
    Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):1998-2002 PMID: 8134338
  19. p53 domains: structure, oligomerization, and transformation.
    Mol Cell Biol. 1994 Aug;14(8):5182-91 PMID: 8035799
  20. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.
    Genes Dev. 1994 May 15;8(10):1235-46 PMID: 7926727
  21. Annexin XIIIb: a novel epithelial specific annexin is implicated in vesicular traffic to the apical plasma membrane.
    J Cell Biol. 1995 Mar;128(6):1043-53 PMID: 7896870
  22. Quantitative monitoring of gene expression patterns with a complementary DNA microarray.
    Science. 1995 Oct 20;270(5235):467-70 PMID: 7569999
  23. Caveolae and caveolins.
    Curr Opin Cell Biol. 1996 Aug;8(4):542-8 PMID: 8791446
  24. Light-directed synthesis of high-density oligonucleotide arrays using semiconductor photoresists.
    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13555-60 PMID: 8942972
  25. Wild-type p53 negatively regulates the expression of a microtubule-associated protein.
    Genes Dev. 1996 Dec 1;10(23):2971-80 PMID: 8956998
  26. p53, the cellular gatekeeper for growth and division.
    Cell. 1997 Feb 7;88(3):323-31 PMID: 9039259
  27. Identification of redox/repair protein Ref-1 as a potent activator of p53.
    Genes Dev. 1997 Mar 1;11(5):558-70 PMID: 9119221
  28. A model for p53-induced apoptosis.
    Nature. 1997 Sep 18;389(6648):300-5 PMID: 9305847
  29. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene.
    Nat Genet. 1997 Oct;17(2):141-3 PMID: 9326928
  30. Exploring the metabolic and genetic control of gene expression on a genomic scale.
    Science. 1997 Oct 24;278(5338):680-6 PMID: 9381177
  31. Genome-wide expression monitoring in Saccharomyces cerevisiae.
    Nat Biotechnol. 1997 Dec;15(13):1359-67 PMID: 9415887
  32. NRP/B, a novel nuclear matrix protein, associates with p110(RB) and is involved in neuronal differentiation.
    J Cell Biol. 1998 May 4;141(3):553-66 PMID: 9566959
  33. Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389.
    Proc Natl Acad Sci U S A. 1998 May 26;95(11):6399-402 PMID: 9600977
  34. Expression monitoring by hybridization to high-density oligonucleotide arrays.
    Nat Biotechnol. 1996 Dec;14(13):1675-80 PMID: 9634850
  35. The p53 proto-oncogene can act as a suppressor of transformation.
    Cell. 1989 Jun 30;57(7):1083-93 PMID: 2525423
  36. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease.
    Science. 1989 Jul 28;245(4916):409-12 PMID: 2547247
  37. Wild-type p53 can inhibit oncogene-mediated focus formation.
    Proc Natl Acad Sci U S A. 1989 Nov;86(22):8763-7 PMID: 2530586
  38. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.
    Cell. 1990 Aug 24;62(4):671-80 PMID: 2143698
  39. Suppression of human colorectal carcinoma cell growth by wild-type p53.
    Science. 1990 Aug 24;249(4971):912-5 PMID: 2144057
  40. Presence of a potent transcription activating sequence in the p53 protein.
    Science. 1990 Aug 31;249(4972):1046-9 PMID: 2144363
  41. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.
    Science. 1990 Aug 31;249(4972):1049-51 PMID: 2144364
  42. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
    Science. 1990 Nov 30;250(4985):1233-8 PMID: 1978757
  43. 14-3-3sigma is a p53-regulated inhibitor of G2/M progression.
    Mol Cell. 1997 Dec;1(1):3-11 PMID: 9659898
  44. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.
    Genes Dev. 1998 Aug 1;12(15):2424-33 PMID: 9694806
  45. E1A signaling to p53 involves the p19(ARF) tumor suppressor.
    Genes Dev. 1998 Aug 1;12(15):2434-42 PMID: 9694807
  46. Enhanced phosphorylation of p53 by ATM in response to DNA damage.
    Science. 1998 Sep 11;281(5383):1674-7 PMID: 9733514
  47. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.
    Science. 1998 Sep 11;281(5383):1677-9 PMID: 9733515
  48. Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition.
    J Biol Chem. 1998 Oct 16;273(42):27047-50 PMID: 9765217
  49. ATM associates with and phosphorylates p53: mapping the region of interaction.
    Nat Genet. 1998 Dec;20(4):398-400 PMID: 9843217
  50. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.
    J Exp Med. 1998 Dec 7;188(11):2033-45 PMID: 9841917
  51. Cluster analysis and display of genome-wide expression patterns.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8 PMID: 9843981
  52. The transcriptional program in the response of human fibroblasts to serum.
    Science. 1999 Jan 1;283(5398):83-7 PMID: 9872747
  53. MyD genes in negative growth control.
    Oncogene. 1998 Dec 24;17(25):3319-29 PMID: 9916994
  54. Mouse models dissect the role of p53 in cancer and development.
    Semin Cancer Biol. 1998;8(5):337-44 PMID: 10101799
  55. The p53 pathway.
    J Pathol. 1999 Jan;187(1):112-26 PMID: 10341712
  56. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.
    Mol Cell. 1999 May;3(5):579-91 PMID: 10360174
  57. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays.
    Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6745-50 PMID: 10359783
  58. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
    Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6937-41 PMID: 10359817
  59. A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells.
    DNA Cell Biol. 1994 Feb;13(2):125-47 PMID: 8179820
  60. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
Article Info
Journal
Genes & development
Abbr.
Genes Dev
ISSN
0890-9369
Published
2000-04-15
Pages
981-93
Language
English
Region
United States
NLM ID
8711660
PMCID
PMC316542
Subset
IM
Grants
NCI NIH HHS · P01 CA041086 · United States
NCI NIH HHS · P01CA41086 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]